In this interview from AAO 2022, Glaucoma Subspecialty Day co-chair Dr. Teresa Chen provides her top highlights from the meeting. Her selections include optic neuropathy and glaucoma from an neuro-ophthalmology perspective, and the 6-year outcomes from the LiGHT study, which examined the use of selective laser trabeculoplasty (SLT) as a first-line treatment for glaucoma and ocular hypertension.

Financial Disclosures: Dr. Arsham Sheybani discloses financial relationships with Allergan (Consultant); Ivantis (Consultant); New World Medical (Consultant); Santen (Consultant). Dr. Teresa Chen discloses no financial relationships.